Managing Pericarditis: Treatment Options

Post written by PHS Staff Writer on May 15, 2023
Share Post:

## Treating Pericarditis Effectively

Pericarditis is an inflammatory condition affecting the pericardium, the delicate sac enveloping the heart. The inflammation can lead to symptoms like chest pain and fever. Pericarditis can present as acute, lasting anywhere from a few days to several weeks, or chronic, persisting for months or even years. It affects individuals of all ages but is notably more prevalent in men compared to women.

 

According to the American Heart Association, about 1 in 1,000 individuals in the general population develops Pericarditis. The incidence has significantly increased in recent years, largely influenced by the COVID-19 pandemic. Research indicates that up to 30% of patients hospitalized with COVID-19 may experience Pericarditis or myocarditis (inflammation of the heart muscle).

 

Treatment Options for Pericarditis

Pericarditis treatment varies based on the inflammation’s intensity and underlying cause. For mild cases, over-the-counter pain relievers like nonsteroidal anti-inflammatory drugs (NSAIDs) may suffice. However, more severe instances often require prescription medications.

 

Colchicine, traditionally used for treating gout (a form of arthritis triggered by uric acid crystal accumulation in joints), has proven effective for Pericarditis as well.

 

Studies highlight that Colchicine can decrease Pericarditis recurrence by up to 50%. It also helps reduce inflammation and alleviate symptoms such as chest pain and fever. Typically, a low dosage of Colchicine, ranging from 0.5 to 1 mg daily, is administered for several months.

 

Treating Post-COVID Pericarditis

Post-COVID Pericarditis is a newly recognized condition emerging due to the COVID-19 pandemic. This form of Pericarditis occurs when patients who have recovered from COVID-19 develop pericardial inflammation weeks to months after the initial infection.

 

The treatment protocol for post-COVID Pericarditis is similar to that of conventional Pericarditis. Given its potential severity, Colchicine has shown promise. A recent study suggests that Colchicine can reduce the risk of recurrent Pericarditis in post-COVID patients by up to 75%.

 

Medications Leading to Pericarditis

Various factors, including infections, autoimmune disorders, and specific medications, can trigger Pericarditis. Certain drugs, such as hydralazine, procainamide, and isoniazid, have been linked to causing Pericarditis.

 

If you are on medication that could induce Pericarditis, it is vital to discuss the associated risks and benefits with your healthcare provider, particularly if you have had COVID-19. Your provider might recommend an alternative medication or adjust your current dosage.

Related Products

There are no related matching items at this time. Please check again soon.